(S)-N-((3-(3-fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)Methyl)ethanethioaMide
≥95%
- Product Code: 54192
CAS:
216868-57-4
Molecular Weight: | 353.41 g./mol | Molecular Formula: | C₁₆H₂₀FN₃O₃S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 524.1±60.0℃(Predicted) | |
Density: | 1.324±0.06 g/cm3(Predicted) | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily used in the development of novel antibiotics, particularly targeting drug-resistant bacterial infections. Its structure is optimized to inhibit bacterial protein synthesis, making it effective against a range of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). It is also studied for its potential in treating tuberculosis, especially strains resistant to conventional therapies. Additionally, its unique mechanism of action reduces the likelihood of cross-resistance with existing antibiotics, enhancing its therapeutic value. Research is ongoing to explore its efficacy in combination therapies and its application in treating other bacterial infections.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | Ft459,332.55 |
+
-
|
(S)-N-((3-(3-fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)Methyl)ethanethioaMide
This compound is primarily used in the development of novel antibiotics, particularly targeting drug-resistant bacterial infections. Its structure is optimized to inhibit bacterial protein synthesis, making it effective against a range of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). It is also studied for its potential in treating tuberculosis, especially strains resistant to conventional therapies. Additionally, its unique mechanism of action reduces the likelihood of cross-resistance with existing antibiotics, enhancing its therapeutic value. Research is ongoing to explore its efficacy in combination therapies and its application in treating other bacterial infections.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :